Custom Index Systems’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$498K Sell
3,341
-277
-8% -$38.9K 0.18% 147
2026
Q2
$457K Buy
3,618
+152
+4% +$20K 0.16% 154
2026
Q1
$483K Sell
3,466
-39
-1% -$5.46K 0.21% 133
2025
Q4
$430K Sell
3,505
-4,225
-55% -$513K 0.19% 150
2025
Q3
$858K Buy
7,730
+2,427
+46% +$276K 0.26% 108
2025
Q2
$588K Buy
5,303
+2,225
+72% +$237K 0.28% 103
2025
Q1
$345K Buy
+3,078
New +$318K 0.17% 186

Other funds holding GILD

Custom Index Systems's GILD Position: Q3 2026 in Review

Custom Index Systems reduced its Gilead Sciences (GILD) stake by 7.7% in Q3 2026, selling an estimated $38.9K and leaving 3,341 shares worth $498K. The position accounts for 0.18% of the portfolio, ranked #147.

Custom Index Systems first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. The position peaked at $858K in Q3 2025. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Custom Index Systems held 3,341 shares of Gilead Sciences worth $498K as of Q3 2026.
  • Custom Index Systems sold 277 Gilead Sciences shares in Q3 2026, an estimated $38.9K.
  • Gilead Sciences made up 0.18% of Custom Index Systems's portfolio in Q3 2026, its #147 holding.
  • Custom Index Systems first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
  • Custom Index Systems's Gilead Sciences position peaked at $858K in Q3 2025.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Custom Index Systems's 13F filing for Q3 2026, filed 12 Nov 2026.